Literature DB >> 19550398

Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation.

S P Yenamandra1, A Lundin, V Arulampalam, M Yurchenko, S Pettersson, G Klein, E Kashuba.   

Abstract

BACKGROUND: Infection of human B cells with Epstein - Barr virus (EBV) induces metabolic activation, morphological transformation, cell proliferation and eventual immortalization. AIM: To identify the nuclear receptors, which are the cellular interaction partners of EBNAs, that will help to elucidate the mechanism of B cell transformation.
METHODS: We have compared the nuclear receptor profile in the naïve and EBV-transformed B-lymphocytes, using TaqMan LDA microfluidic card technology.
RESULTS: Out of 48 nuclear receptor, 17 showed differential expression at the mRNA level. The expression of 5 genes was elevated in EBV-transformed cells, whereas 12 genes were downregulated in lymphoblastoid cells (LCLs). 7 genes were studied at the protein level; 2 genes were up regulated (Nr2F2 and RARA) and 4 genes were down regulated (ERB, NUR77, PPARG, and VDR) in LCLs.
CONCLUSION: The nuclear receptor profiling on EBV infected B cells showed alterations of nuclear receptors expression at both mRNA and protein levels compared with non infected peripheral blood cells. Further analysis on a possible role of each nuclear receptor in EBV induced cell transformation should be performed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550398

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  14 in total

Review 1.  Immunostimulation in the era of the metagenome.

Authors:  Amy D Proal; Paul J Albert; Greg P Blaney; Inge A Lindseth; Chris Benediktsson; Trevor G Marshall
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.

Authors:  Barbara Altieri; Giovanna Muscogiuri; Luigi Barrea; Chantal Mathieu; Carla V Vallone; Luca Mascitelli; Giorgia Bizzaro; Vincenzo M Altieri; Giacomo Tirabassi; Giancarlo Balercia; Silvia Savastano; Nicola Bizzaro; Cristina L Ronchi; Annamaria Colao; Alfredo Pontecorvi; Silvia Della Casa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

3.  Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.

Authors:  Surya Pavan Yenamandra; Ulf Hellman; Bettina Kempkes; Suhas Deoram Darekar; Sabine Petermann; Tom Sculley; George Klein; Elena Kashuba
Journal:  Cell Mol Life Sci       Date:  2010-07-01       Impact factor: 9.261

Review 4.  Vitamin D and autoimmune thyroid diseases: facts and unresolved questions.

Authors:  Giorgia Bizzaro; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 5.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

6.  Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Amy D Proal; Paul J Albert; Trevor G Marshall; Greg P Blaney; Inge A Lindseth
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  In-depth proteomic characterization of endogenous nuclear receptors in mouse liver.

Authors:  Qiongming Liu; Chen Ding; Wanlin Liu; Lei Song; Mingwei Liu; Liang Qi; Tianyi Fu; Anna Malovannaya; Yi Wang; Jun Qin; Bei Zhen
Journal:  Mol Cell Proteomics       Date:  2012-11-29       Impact factor: 5.911

Review 8.  Inflammation and vitamin D: the infection connection.

Authors:  Meg Mangin; Rebecca Sinha; Kelly Fincher
Journal:  Inflamm Res       Date:  2014-07-22       Impact factor: 4.575

9.  The vitamin d receptor and T cell function.

Authors:  Martin Kongsbak; Trine B Levring; Carsten Geisler; Marina Rode von Essen
Journal:  Front Immunol       Date:  2013-06-18       Impact factor: 7.561

10.  Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.

Authors:  Gaurav K Gupta; Tanupriya Agrawal; Monika Pilichowska
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.